Current news and events

Report in Current Biology by Lie-Jensen and Haglund:Parallels between ALIX recruitment during cytokinetic abscission in flies and virus budding in human cells

Anette Lie-Jensen (left) and Kaisa Haglund
Anette Lie-Jensen (left) and Kaisa Haglund

Understanding how abscission between daughter cells during the final stage of cell division, cytokinesis, is accurately controlled is relevant for cancer, because failure in this process may give rise to binucleate cells and in the next cell division chromosomal missegregation, which might cause aneuploidy, a common feature of cancer cells.  In a recent issue of Current Biology, Lie-Jensen and co-authors elucidate a mechanism by which the abscission machinery is recruited to the midbody in the fruit fly Drosophila melanogaster during abscission.

HIV research performed by Jan Terje Andersen's group presented in Aftenposten

Jan Terje Andersen
Jan Terje Andersen

The major national Norwegian newspaper Aftenposten has recently presented the research of Jan Terje Andersen's "Laboratory of Adaptive Immunity and Homeostasis" group in a feature article entitled "Antistoffer may lead to new HIV medicine.

The goal is a brand new long-acting, preventive HIV medicine that is adapted to the most vulnerable among us.

The Innovative science 2019 award-winning LUMIBLAST concept: Fighting brain cancer through photodynamic therapy, using light from within

Theodossis Theodossiou (left) and Kristian Berg
Theodossis Theodossiou (left) and Kristian Berg

Recently Oslo University Hospital was awarded by the European Commission the first prize for best innovative science 2019, for the inception of the idea of the ongoing Future and Emerging Technologies Open project: LUMIBLAST, coordinated by Kristian Berg and Theodossis Theodossiou.

Oslo University Hospital contributions at ESMO 2019 presented by Dagens Medisin

Marianne Guren and Theres Sørlie interviewed by Anne Hafstad.
Marianne Guren and Theres Sørlie interviewed by Anne Hafstad.

The European Society of Medical Oncology (ESMO) Congress 2019 was held in Barcelona September 27th - October 1st, with tens of thousands participants and 3904 abstracts, The Norwegian newspaper for health and medicine - Dagens Medisin - has published several articles presenting Oslo University Hospital researchers contributions. Some of the interviews are shown as videos.

Brain aging in common brain disorders

Tobias Kaufmann
Tobias Kaufmann

In a study just published in Nature Neuroscience, Tobias Kaufmann and colleagues at NORMENT reported that several psychiatric and neurological disorders are associated with an apparent aging of the brain.

The researchers analysed brain images from more than 45.000 individuals, including data on individuals with different psychiatric and neurological disorders. Several of these disorders were associated with an apparent aging of the brain, with particular strong effects in dementia, multiple sclerosis and schizophrenia.

2019 Innovation Radar Prize for Innovative Science to Lumiblast

The European Commission has awarded prizes to Europe's most promising innovations emerging from EU funded research and innovation projects. 
The prize for Innovative Science, which recognizes cutting-edge science underpinning tomorrow's technological advances, was awarded to Oslo University Hospital for their work to bring Lumiblast, a minimally-invasive clinical treatment for cancer cells in hard to reach areas such as brain cancers, closer to clinical use. The OUH Lumiblast team consists of professor Kristian Berg, dr. Theodossis Theodossiou and dr. Quian Peng.

Holmenkollen Park Hotel September 18-20th 2019:18th Annual CHFR Symposium on Heart Research

The Center for Heart Failure Research (CHFR) was established in 2002 and has since then promoted the integration of high quality research from bench to bedside. Center members have a broad range of expertise, covering state-of-the-art gene technology, protein function, integrative physiology in pathophysiological models and clinical studies. This collective knowledge and active research collaboration has resulted in more than 200 scientific publications each year.

The Annual Symposiums that began in 2003 have constituted an important platform for networking, introduction of up-and-coming academic talents, along with impressive research results, not to mention the presence of important international speakers shedding light on recent advancements in cardiovascular research.

Center for Cardiological Innovation (CCI) partners granted a new EU-financed project

Thor Edvardsen (left) and Kristina Haugaa from OUS with Eigil Samset from GE Vingmed Ultrasound
Thor Edvardsen (left) and Kristina Haugaa from OUS with Eigil Samset from GE Vingmed Ultrasound

GE Vingmed Ultrasound together with Oslo University Hospital, the University of Oslo, KU Leuven, the University of Maastrich, Jessa Hospital in Belgium and Medaphor were recently awarded 1.6 million euros for a Marie Curie project that will utilize artificial intelligence to diagnose a number of heart disorders. Several of the international partners in the new project have previously been central to CCI's international research collaboration.

H2020 funding for exploration of the secretory pathways to identify candidate biomarkers or therapeutic targets

Gunhild Mælandsmo (left) and Lina Prasmickaite
Gunhild Mælandsmo (left) and Lina Prasmickaite

The project SECRET (Exploration of the SECRETory pathway for cancer therapy) has been funded 4 mill EUR from H2020 to establish a Marie Skłodowska-Curie Innovative Training Network (H2020-MSCA-ITN). The objective of SECRET is to improve the understanding of the mutual regulation of the secretory pathway and cell signaling to identify and interrogate novel diagnostic and therapeutic strategies for application in breast- and colorectal cancer. Two Norwegian researchers are partners, Prof Gunhild M. Mælandsmo, Institute for Cancer Research (ICR), Oslo University Hospital and Prof Hesso Farhan, Institute of Basic Medical Science (IMB), University of Oslo, together receiving funding for three Early Stage Researchers (ERS).


More news from the archive